Want to see AMGN full AI Analyst Report?
Amgen (AMGN) Stock Statistics & Valuation Metrics
Total Valuation
Amgen has a market cap or net worth of $249.37B. The enterprise value is $270.96B.
- Market Cap
- $249.37B
- Enterprise Value
- $270.96B
Share Statistics
Amgen has 540,632,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 540,632,000
- Owned by Insiders
- 0.21%
- Owned by Institutions
- 59.52%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 13.16%.
- Return on Equity (ROE)
- 0.89
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 13.16%
- Return on Capital Employed (ROCE)
- 0.16
- Revenue Per Employee
- 1.17M
- Profits Per Employee
- 244.79K
- Employee Count
- 31,500
- Asset Turnover
- 0.41
- Inventory Turnover
- 1.72
Valuation Ratios
The current PE Ratio of Amgen is 26.48. Amgen’s PEG ratio is 0.79.
- PE Ratio
- 26.48
- PS Ratio
- 6.39
- PB Ratio
- 17.35
- Price to FCF
- 25.97
- Price to Operating Cash Flow
- 20.69
- PEG Ratio
- 0.79
Income Statement
In the last 12 months, Amgen had revenue of 36.74B and earned 7.71B in profits. Earnings per share was 14.33.
- Revenue
- 36.74B
- Gross Profit
- 26.01B
- Operating Income
- 10.68B
- Pretax Income
- 8.98B
- Net Income
- 7.71B
- EBITDA
- 16.90B
- Earnings Per Share (EPS)
- 14.33
Cash Flow
In the last 12 months, operating cash flow was 12.04B and capital expenditures -2.45B, giving a free cash flow of 9.58B billion.
- Operating Cash Flow
- 12.04B
- Free Cash Flow
- 9.58B
- Free Cash Flow per Share
- 17.71
Dividends & Yields
Amgen pays an annual dividend of $2.52, resulting in a dividend yield of 2.08%
- Dividend Per Share
- $2.52
- Dividend Yield
- 2.08%
- Payout Ratio
- 44.34%
- Free Cash Flow Yield
- 3.83%
- Earnings Yield
- 3.75%
Stock Price Statistics
- Beta
- 0.32
- 52-Week Price Change
- 43.90%
- 50-Day Moving Average
- 420.73
- 200-Day Moving Average
- 374.10
- Relative Strength Index (RSI)
- 73.41
- Average Volume (3m)
- 2.75M
Important Dates
Amgen upcoming earnings date is Feb 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 09, 2027
- Ex-Dividend Date
- May 15, 2026
Financial Position
Amgen as a current ratio of 1.14, with Debt / Equity ratio of 630.68%
- Current Ratio
- 1.14
- Quick Ratio
- 0.90
- Debt to Market Cap
- 0.31
- Net Debt to EBITDA
- 2.69
- Interest Coverage Ratio
- 3.88
Taxes
In the past 12 months, Amgen has paid 1.26B in taxes.
- Income Tax
- 1.26B
- Effective Tax Rate
- 0.14
Enterprise Valuation
Amgen EV to EBITDA ratio is 16.02, with an EV/FCF ratio of 30.39.
- EV to Sales
- 7.48
- EV to EBITDA
- 16.02
- EV to Free Cash Flow
- 30.39
- EV to Operating Cash Flow
- 24.19
Balance Sheet
Amgen has $13.19B in cash and marketable securities with $54.01B in debt, giving a net cash position of -$40.82B billion.
- Cash & Marketable Securities
- $13.19B
- Total Debt
- $54.01B
- Net Cash
- -$40.82B
- Net Cash Per Share
- -$75.50
- Tangible Book Value Per Share
- -$44.08
Margins
Gross margin is 73.97%, with operating margin of 35.53%, and net profit margin of 24.12%.
- Gross Margin
- 73.97%
- Operating Margin
- 35.53%
- Pretax Margin
- 28.39%
- Net Profit Margin
- 24.12%
- EBITDA Margin
- 46.67%
- EBIT Margin
- 35.16%
Analyst Forecast
The average price target for Amgen is $448.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $448.17
- Price Target Upside
- 2.63% Downside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 26
- Revenue Growth Forecast
- 8.62%
- EPS Growth Forecast
- 33.48%
Scores
- Smart Score
- 9
- AI Score
- 75
